Clinical Trial

Additional Effects of Sternocleidomastoid Release With SNAGS in the Management of Cervicogenic Headache

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated December 10, 2024 completion). Its status may not reflect the trial's current state.
Summary
Cervicogenic headache is a common type of headache in adults which causes disability and difficulty in everyday activities. According to the latest International Headache Society model, cervicogenic headache (CGH) is a secondary headache having C1-C2 dysfunction. SNAGs are highly effective in the treatment approach for these patients. Sternocleidomastoid muscle receive overactive tension from forward neck posture, increasing muscular fatigue and tone of muscles. This tension in SCM causes referred pain in the head and neck region. SNAGs are very effective but musculoskeletal impairments especially the tightness of sternocleidomastoid muscle still persist and can exacerbate symptoms. Manual therapy targeted to the SCM muscle may be effective for reducing headache and neck pain intensity and increasing performance of deep cervical flexors. Findings of this study will aid the therapists in choosing which technique to use while treating the patients. This will save therapist's time and effort as they will not be using the less effective treatment protocol. Furthermore, patient's time and investment will be used in the right direction.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06534606
Lead Sponsor Foundation University Islamabad
Conditions Cervicogenic Headache
Enrollment 38 participants
Start Date 2024-06-10
Primary Completion 2024-12-10 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-02